Nurtec Odt Tablet, Orally Disintegrating
NDC Package 85766-096-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nurtec Odt (rimegepant sulfate) tablets is nURTEC ODT is contraindicated in patients with a history of hypersensitivity reaction to rimegepant, NURTEC ODT, or any of its components.Reactions have included anaphylaxis and delayedserious hypersensitivity [see Warnings andPrecautions (5.1)]. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Sportpharm Llc, this product is identified by NDC 85766-096 and is authorized under FDA application NDA212728.

Identification & Billing

NDC Package Code
85766-096-08
Package Description
1 BLISTER PACK in 1 CARTON / 8 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product Code
85766-096
11-Digit Billing Format
85766009608
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nurtec Odt
Non-Proprietary Name
Rimegepant Sulfate
Substance Name
Rimegepant Sulfate
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
RIMEGEPANT SULFATE 75 mg/1
Pharmacologic Class
Usage Information
NURTEC ODT is contraindicated in patients with a history of hypersensitivity reaction to rimegepant, NURTEC ODT, or any of its components.Reactions have included anaphylaxis and delayedserious hypersensitivity [see Warnings andPrecautions (5.1)] .

Regulatory & Marketing

Labeler Name
Sportpharm Llc
Product Type
Human Prescription Drug
FDA Application #
NDA212728
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-05-2020
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85766-096-08 identifies a specific commercial package of 1 blister pack in 1 carton / 8 tablet, orally disintegrating in 1 blister pack of Nurtec Odt, a human prescription drug labeled by Sportpharm Llc. This tablet, orally disintegrating is formulated for oral use and contains rimegepant sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sportpharm Llc on March 05, 2020. The current certification is valid through December 31, 2027.

How is this Sportpharm Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85766009608. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85766-096-08
11-Digit CMS (5-4-2)
85766-0096-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.